ClinicalTrials.gg
Drug

Bexarotene clinical trials

Also written Targretin and LGD1069.

studies test it
33
open now
1
in phase 3
6
first study started
1998

How each study uses Bexarotene is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Bexarotene studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Dec 1999 · TARGRETIN · NDA 021055 (FDA, Drugs@FDA)
European Union
29 Mar 2001 · Targretin · EMEA/H/C/000326 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bexarotene
25
Bexarotene (targretin)
2

Brand

Targretin
12

Development codes

LGD1069
2

Studies by the year they started

30 studies that test it; most in 2001 (5)

Studies that test Bexarotene, by start year
YearStudies
19981
20015
20021
20032
20042
20054
20062
20071
20083
20104
20131
20141
20181
20201
20221

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
12
Phase 2
18
Phase 3
6
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 26

Memorial Sloan Kettering Cancer Center (3) · M.D. Anderson Cancer Center (2) · Abramson Cancer Center at Penn Medicine (2) · Ligand Pharmaceuticals (2) · Eisai Inc. (2) · Beersheva Mental Health Center (2) · Stanford University (1) · National Cancer Centre, Singapore (1)

Often tested with

Tested in the same studies.

Erlotinib (2) · Gefitinib (1) · Pralatrexate (1) · Rosiglitazone (1) · Gemcitabine (1) · Decitabine (1) · Carboplatin (1) · Paclitaxel (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Bexarotene.

Studies

Open first, then newest update. How each study uses Bexarotene is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 33

See all 33 studies that test Bexarotene →

Given beside what is tested · 5 — Bexarotene is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Bexarotene

Codes

What other systems call Bexarotene · ClinicalTrials.gg INT006780

  • MeSH (NLM) D000077610BexaroteneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) A61RXM4375BEXAROTENEConfirmed FDA, NLM, Wikidata
  • RxNorm 233272Confirmed FDA, Wikidata
  • Wikidata Q418192bexaroteneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1635BexaroteneOne source FDA
  • DrugBank DB00307One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.